Therapeutic Advancements in Psoriasis and Psoriatic Arthritis

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Immunology".

Deadline for manuscript submissions: 25 July 2024 | Viewed by 108

Special Issue Editors


E-Mail Website
Guest Editor
Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy
Interests: dermatology; psoriasis; basal cell carcinomas; alopecia; vitiligo

E-Mail Website
Guest Editor
Section of Dermatology and Venereology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
Interests: psoriasis; psoriatic arthritis; biologics; small molecules; cytokines
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

In recent years, many advances in science have provided a better understanding of the pathogenesis of psoriasis and psoriatic arthritis. This facilitated the identification of many new therapeutic targets, such as those blocking the main pro-inflammatory cytokines involved in the pathogenesis of this disease. Research has particularly focused on systemic agents for the treatment of moderate-to-severe psoriasis and psoriatic arthritis, particularly with the introduction of biologic agents and "small molecules". Treatment selection for psoriasis and psoriatic arthritis may be challenging and different factors have to be considered when choosing the right treatment for the right patient at the right time.

For this Special Issue, we invite authors to present articles on therapeutic advances in the treatment of psoriasis and psoriatic arthritis, including both data trials and real-life experiences.

Dr. Vincenzo Picone
Dr. Sara Cacciapuoti
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • psoriasis
  • psoriatic arthritis
  • biologics
  • small molecules
  • cytokines

Published Papers

This special issue is now open for submission.
Back to TopTop